| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| TYNDALL JOSEPH A. | Director | C/O AXOGEN, INC. 13631 PROGRESS BLVD.,, SUITE 400, ALACHUA | /s/ Marc Began as attorney-in-fact for Joseph A. Tyndall | 2025-06-11 | 0001955281 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | AXGN | Common Stock | Options Exercise | $47.8K | +7.59K | +49.44% | $6.30 | 22.9K | Jun 10, 2025 | Direct | |
| transaction | AXGN | Common Stock | Options Exercise | $28.2K | +4K | +17.44% | $7.04 | 26.9K | Jun 10, 2025 | Direct | |
| transaction | AXGN | Common Stock | Sale | -$289K | -26.9K | -100% | $10.72 | 0 | Jun 10, 2025 | Direct | F1 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | AXGN | Stock Option (right to purchase) | Options Exercise | -$47.8K | -7.59K | -100% | $6.30 | 0 | Jun 10, 2025 | Common Stock | 7.59K | $6.30 | Direct | F2 |
| transaction | AXGN | Employee Stock Option (right to purchase) | Options Exercise | -$28.2K | -4K | -21.92% | $7.04 | 14.2K | Jun 10, 2025 | Common Stock | 4K | $7.04 | Direct | F3 |
| Id | Content |
|---|---|
| F1 | The reported price in Column 4 is a weighted average sale price. These shares were sold on June 10, 2025 in multiple transactions at prices ranging from $10.69 to $10.83 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. |
| F2 | Options vested on the first anniversary of the grant date, which was September 1, 2023. |
| F3 | Options vested on the first anniversary of the grant date, which was June 6, 2024. |